Discounted Cash Flow
ICU Medical Inc./de
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $379.4m | $63.1m | $66.6m | 16.6% | $3.90 |
| 2017 | $1.3b (240.7%) | $68.6m (8.8%) | $79.9m (20.1%) | 5.3% (-68.1%) | $3.50 (-10.3%) |
| 2018 | $1.4b (8.3%) | $28.8m (-58.1%) | $67.5m (-15.6%) | 2.1% (-61.3%) | $1.41 (-59.7%) |
| 2019 | $1.3b (-9.6%) | $101.0m (250.9%) | $4.6m (-93.2%) | 8.0% (288.0%) | $4.90 (247.5%) |
| 2020 | $1.3b (0.4%) | $86.9m (-14.0%) | $130.7m (2738.6%) | 6.8% (-14.3%) | $4.16 (-15.1%) |
| 2021 | $1.3b (3.6%) | $103.1m (18.7%) | $199.0m (52.2%) | 7.8% (14.6%) | $4.86 (16.8%) |
| 2022 | $2.3b (73.2%) | $-74.3m (-172.0%) | $-152.4m (-176.6%) | -3.3% (-141.6%) | $-3.11 (-164.0%) |
| 2023 | $2.3b (-0.9%) | $-29.7m (60.1%) | $82.3m (154.0%) | -1.3% (59.7%) | $-1.23 (60.5%) |
| 2024 | $2.4b (5.4%) | $-117.7m (-296.9%) | $124.7m (51.5%) | -4.9% (-276.4%) | $-4.83 (-292.7%) |
| 2025 | $2.2b (-6.3%) | $732.0k (100.6%) | $91.8m (-26.4%) | 0.0% (100.7%) | $0.03 (100.6%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.